Cell-surface glycosaminoglycans: turnover in cultured human embryo fibroblasts (IMR-90)
- PMID: 6772652
- DOI: 10.1002/jcp.1041030313
Cell-surface glycosaminoglycans: turnover in cultured human embryo fibroblasts (IMR-90)
Abstract
As constituents of both extracellular matrix and the cell surface, glycosaminoglycans are in a strategic position to influence several basic cell features. The localization and turnover of glycosaminoglycans was investigated in cultured normal human embryo fibroblasts of lung origin (IMR-90). Attention was directed particularly toward that compartment of the culture which could be released by gentle proteolysis (trypsin, 0.1 mg/ml, 15 min) and is considered to represent the cell surface. In the presence of NA2SO4, sulfated glycosaminoglycans (S-GAGs) of the cell surface were labeled rapidly, but within 30 min some 35S-GAG appeared in the extracellular medium. The intracellular pool of S-GAGs labeled during a 10-min period was lost during the first hr of chase with a half-life of 18 min, compared with 16 hr for S-GAGs labeled over a 48-hr period. Pulse-labeled S-GAGs of the surface turned over with an initial half-life of 60 min, compared with 7 hr for surface material labeled over a 48-hr period. These rapid movements of the early chase period were followed by similar movement at a much slower rate. The results are consistent with a model in which most of the S-GAGs synthesized in the cell move rapidly to the surface. The surface GAGs are then released immediately to the medium or accumulate at the membrane to be shed more slowly at a later time or to be degraded. The S-GAG which left the cell layer most rapidly during chase was dermatan sulfate, while heparan sulfate made up an increasing percentage of the cell layer as chase progressed. These cultures produce a fibrillar matrix of fibronectin, but the kinetics of this study suggest that the S-GAGs of the surface are membrane-bound, and an extracellular glycosaminoglycan matrix does not form.
Similar articles
-
Glycosaminoglycan synthesis and composition in human fibroblasts during in vitro cellular aging (IMR-90).J Cell Physiol. 1981 May;107(2):271-81. doi: 10.1002/jcp.1041070214. J Cell Physiol. 1981. PMID: 7251685
-
Synthesis and secretion of glycosaminoglycans in cultured retinal pigment epithelium.Invest Ophthalmol Vis Sci. 1987 Apr;28(4):618-27. Invest Ophthalmol Vis Sci. 1987. PMID: 3104227
-
Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.J Surg Res. 2000 Jul;92(1):45-52. doi: 10.1006/jsre.2000.5840. J Surg Res. 2000. PMID: 10864481
-
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders.Annu Rev Biomed Eng. 2017 Jun 21;19:1-26. doi: 10.1146/annurev-bioeng-071516-044610. Epub 2017 Feb 2. Annu Rev Biomed Eng. 2017. PMID: 28226217 Review.
-
Sulfated glycosaminoglycans in protein aggregation diseases.Glycoconj J. 2017 Aug;34(4):453-466. doi: 10.1007/s10719-017-9769-4. Epub 2017 Apr 11. Glycoconj J. 2017. PMID: 28401373 Review.
Cited by
-
Production of proteoglycans by human lung fibroblasts (IMR-90) maintained in a low concentration of serum.Biochem J. 1982 Dec 1;207(3):369-79. doi: 10.1042/bj2070369. Biochem J. 1982. PMID: 7165697 Free PMC article.
-
Mouse Cytomegalovirus Differentially Exploits Cell Surface Glycosaminoglycans in a Cell Type-Dependent and MCK-2-Independent Manner.Viruses. 2019 Dec 27;12(1):31. doi: 10.3390/v12010031. Viruses. 2019. PMID: 31892128 Free PMC article.
-
Conditioning of native substrates by chondroitin sulfate proteoglycans during cardiac mesenchymal cell migration.J Cell Biol. 1986 Dec;103(6 Pt 1):2475-87. doi: 10.1083/jcb.103.6.2475. J Cell Biol. 1986. PMID: 3782305 Free PMC article.
-
Synthesis of glycosaminoglycans in fibroblasts from abortuses with trisomy, triploidy, and from children with Down's syndrome.Hum Genet. 1991 Sep;87(5):592-6. doi: 10.1007/BF00209019. Hum Genet. 1991. PMID: 1833305
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials